System and method for catheter system with radioprotective core
The catheter system with a radioprotective core and biocompatible sleeve addresses the limitation of radiotoxicity in radiation therapy by reducing radiation exposure to surrounding tissues, enabling higher doses to be delivered to the target area, thus improving treatment outcomes.
Patent Information
- Application Number
- PCT/US2024/031698
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-05-31
- Filing Date
- 2024-05-30
- Publication Date
- 2024-12-05
AI Technical Summary
Current radiation therapy is limited by radiotoxicity, which restricts the radiation dose that can be delivered to cancer or other pathologies due to the sensitivity of surrounding tissues, leading to inadequate treatment outcomes.
A catheter system comprising a radioprotective core made from materials like lead, tungsten, or bismuth, combined with a biocompatible sleeve, is designed to absorb or scatter radiation, reducing the dose received by nearby tissues during therapy.
The catheter system effectively reduces radiation toxicity to surrounding tissues, allowing for increased radiation doses to be delivered to the target area, thereby enhancing the efficacy of radiation therapy while protecting non-targeted tissues.
Smart Images

Figure US2024031698_05122024_PF_FP_ABST
Abstract
Description
SYSTEM AND METHOD FOR CATHETER SYSTEM WITH RADIOPROTECTIVE CORE RELATED APPLICATIONS
[0001] This application is based on, claims priority to, and incorporates herein by reference for all purposes, U.S. Provisional Patent Application No.63 / 469,953 filed on May 31, 2023. STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH
[0002] N / A BACKGROUND
[0003] Radiation dose is limited by radiotoxicity of the surrounding tissue. Thus, many patients will not receive a dose that is clinically sufficient, leaving cancer or other pathologies behind. For example, radiation of prostate cancer is limited by radiotoxicity of the urinary system, including the urethra, which can cause necrosis, pain, and so forth. Thus, new systems and methods are needed that control against radiotoxicity to maximize the allowed dose to the target pathology. SUMMARY
[0004] In some aspects, the present disclosure provides a catheter system for use with radiation therapy. The catheter system can include a core that is formed from a radioprotective material. The core may extend from a proximal end to a distal end along a longitudinal axis. The catheter system further includes a sleeve formed from a biocompatible material that extends about the core along the longitudinal axis. The sleeve may have an outer wall that is configured to extend through a biological lumen of a patient. The sleeve and the core are configured to cooperate to reduce a radiation dose received by tissue or organs in the patient that are proximate to the catheter system. The core may absorb or scatter radiation incident upon the radioprotective material, and the sleeve may absorb at least some of the radiation scattered by the core.
[0005] In other aspects, the present disclosure provides a catheter system for use with radiation therapy. The catheter system can include a core formed from a radioprotective material that extends from a proximal end to a distal end along a longitudinal axis. The core may be configured to absorb or scatter radiation incident upon the radioprotective material, reducing aradiation dose received by tissue or organs in the patient proximate to the catheter system. The catheter system further includes a sleeve formed from biocompatible material. The sleeve may extend about the core along the longitudinal axis and have an outer wall. The catheter system may be configured to extend through a biological lumen of a patient.
[0006] In other aspects, the present disclosure provides a method of manufacturing a radioprotective catheter system. The method includes forming a core that extends from a proximal end to a distal end along a longitudinal axis. The core may comprise a radioprotective material. The method further includes forming a sleeve around the core along the longitudinal axis to form a closed lumen surrounding the core. The sleeve may be formed from a biocompatible material. The catheter system may be configured to extend through a biological lumen of a patient. DESCRIPTION OF THE DRAWINGS
[0007] Various objects, features, and advantages of the disclosed subject matter can be more fully appreciated with reference to the following detailed description of the disclosed subject matter when considered in connection with the following drawings, in which like reference numerals identify like elements.
[0008] FIG.1 is a plan view of a radioprotective catheter according to some aspects of the present disclosure.
[0009] FIG.2 is a cross-sectional view of an example radioprotective catheter according to some aspects of the present disclosure.
[0010] FIG.3 is another cross-sectional view of another example radioprotective catheter according to further aspects of the present disclosure.
[0011] FIG.4 is a plan view of another example catheter according to some aspects of the present disclosure.
[0012] FIG.5A is an example cross-sectional view of the catheter of FIG.4 according to some aspects of the present disclosure.
[0013] FIG.5B is an example cross-sectional view of the catheter of FIG.4 according to other aspects of the present disclosure.
[0014] FIG.5C illustrates an example cross-sectional view of the catheter of FIG.4according to further aspects of the present disclosure.
[0015] FIG.6 shows plan and detailed views of another example catheter according to some aspects of the present disclosure.
[0016] FIG.7 is an example model used to calculate dose reduction for a radioprotective catheter according to some aspects of the present disclosure.
[0017] FIG.8 is a graph of example radiation dose profiles for various core materials according to some aspects of the present disclosure. DETAILED DESCRIPTION
[0018] Before any embodiments of the invention are explained in detail, it is to be understood that the invention is not limited in its application to the details of construction and the arrangement of components set forth in the following description or illustrated in the following drawings. The invention is capable of other embodiments and of being practiced or of being carried out in various ways. Also, it is to be understood that the phraseology and terminology used herein is for the purpose of description and should not be regarded as limiting. The use of “including,” “comprising,” or “having” and variations thereof herein is meant to encompass the items listed thereafter and equivalents thereof as well as additional items. Unless specified or limited otherwise, the terms “mounted,” “connected,” “supported,” and “coupled” and variations thereof are used broadly and encompass both direct and indirect mountings, connections, supports, and couplings. Further, “connected” and “coupled” are not restricted to physical or mechanical connections or couplings.
[0019] The following discussion is presented to enable a person skilled in the art to make and use embodiments of the invention. Various modifications to the illustrated embodiments will be readily apparent to those skilled in the art, and the generic principles herein can be applied to other embodiments and applications without departing from embodiments of the invention. Thus, embodiments of the invention are not intended to be limited to embodiments shown, but are to be accorded the widest scope consistent with the principles and features disclosed herein. The following detailed description is to be read with reference to the figures, in which like elements in different figures have like reference numerals. The figures, which are not necessarily to scale, depict selected embodiments and are not intended to limit the scope of embodiments of the invention. Skilled artisans will recognize the examples provided herein have many useful alternatives and fall within the scope of embodiments of the invention.
[0020] The present disclosure provides a radioprotective catheter that may be used in conjunction with radiation therapy to protect surrounding tissue from radiotoxicity. For example, the catheter may be placed inside a biological lumen during radiation therapy to act as a radioprotectant to reduce the radiation dose received by surrounding or non-targeted tissues. In one, non-limiting example the biological lumen may be a urethra, rectum, esophagus, or other structure and the radiation therapy may be targeting the prostate or other nearby organ. As will be described, the radioprotective catheter may protect proximate non-targeted structures, such as to protect rectal mucosa or vaginal mucosa, esophagus or nasopharynx, or other structures, depending upon the location of the target structure or anatomy. The catheter may be formed using multiple materials and / or have multiple layers. As one, non-limiting example, the catheter may include an outer lumen or sleeve and an inner core. The inner core may be soft or flexible and capable of bending sufficiently to facilitate insertion into the biological lumen, such as urethra or other anatomical structure. Furthermore, the core may be formed from or include a radio-opaque or radio-protective material. The catheter may have an optional balloon port, balloon inflation lumen, and balloon that can inflate in the bladder of a patient or subject to help maintain the catheter in a desired position while in use.
[0021] Referring to FIGS.1 and 2, one example of a catheter system 100 is illustrated. FIG. 1 shows a plan view of the catheter system 100. The catheter system 100 includes a closed outer layer or external sleeve 102. The sleeve 102 may be formed from a biocompatible material that can be inserted into a patient. The catheter system 100 can have a distal end 106 that is configured to be inserted into a patient’s biological lumen, for example into a urethra, and a proximal end 104 designed to provide access to the catheter system 100 from the outside of the patient while the distal end 106 is inserted into the patient. Thus, the catheter system 100 extends from the proximal end 104 to the distal end 106 along a longitudinal axis 108. The catheter system 100 can have a length 109 sufficient to reach the target anatomy. For example, the length 109 may be designed to reach from the outside of the patient to the bladder of the patient. As a non-limiting example, the length may be, in one, non-limiting example 1-24 inches, including 16 inches.
[0022] FIG.2 shows a cross-sectional view of the catheter system 100 through a surface of the catheter system 100 that is perpendicular to the longitudinal axis 108. As described, the catheter system 100 may include the sleeve 102 that forms an outer wall 110 and an inner wall112. The outer wall 110 defines an outer circumference extending along a circumferential direction 114 defined by an angle θ 116.
[0023] As FIG.2 illustrates, the catheter system 100 can have a core 118. The core 118 may be formed of a flexible material that has radioprotective properties, which may be referred to as a “radioprotectant” because it absorbs, reflects, or otherwise controls the transmission of ionizing radiation through the core 118. This radioprotective material can help to protect tissues or organs that are proximate to the catheter system 100 by reducing the radiation dose such tissues receive. In one example, the core 118 provides a flexible, low half-value layer (HVL) to block transmission of radiation therethrough. The HVL describes the thickness of material penetrated by ½ of the radiation as a function of the incident energy. For example, the core 118 may include lead, which is low in cost, highly accessible, and has a high rate of radiation attenuation. Table I shows the HVL of lead compared to that of tissue and aluminum for three different energy levels. Table I: HVL values Material HVL at 30 keV HVL at 60 keV HVL at 120 keV Tissue 20.0 35.0 45.0 Aluminum 2.3 9.3 16.6 Lead 0.02 0.125 0.15
[0024] Radioprotective materials that may be incorporated into the core 118 can also be described based on linear attenuation coefficients according to: ୪୬^^బ^^^^^ ൌ (1)
[0025] intensity of the beam at distance x, and ^^^is the intensity of the beam at its origin. Similarly, the mass coefficient can be described as: ୪୬^^బఓ^^^(2)
[0026]
[0027] The core 118 may additionally or alternatively include other radioprotective materials, such as tungsten, titanium, bismuth, gold, osmium, uranium, tantalum, impregnated polymer composite materials, or a combination thereof. The core 118 may be constructed from a soft or flexible material, such as soft lead, or include quantities of a plurality of materialsselected to allow for sufficient flexibility or bending to insert the catheter system 100 into the body of the patient, for example in the urethra.
[0028] In some configurations, the sleeve 102 can be used to protect the core 118 and / or protect the biological lumen of the patient from direct interaction with the core 118. In this way, the sleeve 102 can provide a barrier between the core 118 and the patient. The core 118 may be co-extensive with or may only extend along a part or portion of the sleeve 102. The sleeve 102 may fully surround the core 118, forming a closed lumen such that none of the core 118 is exposed to the patient or user. For example, the sleeve 102 can fully surround the core 118 in a circumferential direction transverse to the longitudinal axis 108. The sleeve 102 may be constructed from biocompatible materials, such as silicone, latex rubber, polytetrafluoroethylene (e.g., Teflon®), or others, including Polyvinylchloride (PVC), polyethylene (PE), polypropylene (PP), polymethylmethacrylate (PMMA). In this way, the sleeve 102 and core 118 can be configured to cooperate to provide radiation dose reduction via the radioprotective properties of the core 118 while providing a barrier between the core and the patient via the biocompatible properties of the sleeve 102.
[0029] Furthermore, the sleeve 102 can be dimensioned and designed to create a space to absorb scattered radiation that is reflected off the radioprotective core 118. The sleeve 102 may function to absorb radiation scatter that is reflected by the surface of the core 118. Thus, as will be described, a thickness of the sleeve 102 can be selected based on the tradeoff between patient comfort and the level of scatter protection.
[0030] The cross-sectional area of the sleeve 102 may be circular, nearly circular, elliptical, another geometric shape, or another abnormal shape. The sleeve 102 can be characterized with a distance Ds120 that describes the length or distance across the cross-sectional area of the sleeve 102. For example, if the sleeve 102 is circular, Ds 120 may be the diameter of the sleeve 102 measured at the outer wall 110. Ds 120 may also describe the average distance across the cross- sectional area of the sleeve 102. Alternatively, Ds120 can describe the distance from a position on the outer wall 110 of the sleeve 102, through the center 111 of the cross-sectional area of the catheter system 100 to the periphery or outer wall 110 of the sleeve 102 as a function of the position around the circumferential direction 114, e.g., Ds(θ) for 0° ≤ θ < 360°. The sleeve 102 may also be characterized by a thickness Ts122 that describes the distance between the outerwall 110 and the inner wall 112 of the sleeve 102. Ts 122 may also be uniform about the core 118 or may vary and be described as a function of θ (e.g., Ts(θ) for 0° ≤ θ < 360°.
[0031] Similarly, the cross-sectional area of the core 118 may be circular, nearly circular, elliptical, another geometric shape, or another abnormal shape. The core 118 can be characterized with a distance Dc 124 that describes the length or distance across the cross- sectional area of the core 118. For example, if the core 118 is circular, Dc124 may be the diameter of the core 118. Dc124 may also describe the average distance across the cross- sectional area of the core 118. Alternatively, Dc 124 can describe the distance between a position on the periphery of the core 118, through the center 111 of the cross-sectional area of the catheter system 100 and to a position on the opposite periphery of the core 118 as a function of the position in the circumferential direction 114, e.g., Dc(θ) for 0° ≤ θ < 360°. In some configurations, Dc 124 may be approximately equal to an inner distance across opposing sides of the inner wall 112 of the sleeve 102. Put another way, the periphery of the core 118 may abut the inner wall 112 of the sleeve 102. In other configurations, these dimensions may vary to facilitate insertion and removal of the core 118 from the sleeve 102, if desired.
[0032] The dimensions of the catheter (e.g., Dc, Ds, Ts) may be chosen to fit into a target lumen (e.g., urethra) of a patient or subject while also maximizing or increasing radiation protection. The distance Dc 124 may be determined based on the tradeoff between patient comfort and radiation attenuation. Similarly, the distance Ds120 and thickness Ts122 may be determined based on the tradeoff between patient comfort and scatter absorption. For example, the maximum distance Ds of the sleeve may be set to the minimum inner diameter of the urethra. The maximum Ds120 may also be determined based on patient tolerance or the ability to insert the catheter system 100. In a non-limiting example, Ds120 may be limited by the maximum value 12 mm, 10 mm, 8 mm, 6 mm, 4 mm, or other value selected based on patient considerations and radiation considerations. The lower limit of Ds 120 may be set to achieve sufficient radiation scatter absorption based on the material of the core 118 and the sleeve 102. For example, the minimum Ds 120 may be set to 2 mm, 4 mm, 6 mm, 8 mm, 10 mm, and so forth. As a non-limiting example, the thickness Ts 122 may have a value within a range of 0.1 mm to 2 mm. Similarly, Dc124 may be limited by a maximum of 12 mm, 10 mm, 8 mm, 6 mm, or 4 mm, or the like and / or a minimum of 1 mm, 2 mm, 4 mm, 6 mm, 8 mm, 10 mm, or the like.
[0033] The core 118 may have the same or different shape as the sleeve 102. The core 118 can be centered inside the sleeve 102 or may be offset. A non-limiting example of another catheter system 300 is shown in FIG.3, in which Tsis a value that is a function of the position around the circumference, θ, e.g. Ts(θ1) 302 and Ts(θ2) 304. For example, when the incidence of radiation treatment is known, the catheter system 300 may be deployed with the thicker region of the sleeve (e.g., Ts(θ1) 302) aligned with a radiation source 306 and the thinner region of the sleeve (e.g., Ts(θ2) 304) opposite of the radiation source, as shown in FIG.3. In this way, the thickness of the sleeve 102 can be maximized or increased in the region of radiation scatter, while also maximizing the pathlength of the radiation beams through the core 118.
[0034] The shapes and distances (e.g., Dc124 and Ds120) of the cross-sectional areas of the core 118 and sleeve 102 may be constant across axis 108 for the whole length 109 of the catheter system. Alternatively, they may vary along the length of the catheter system. For example, the core 118, sleeve 102, or both may have increasing sizes (e.g., Dc, Ds, or both) along axis 108 in the distal direction. In this way, the catheter system 100, 300 can have increased radiation protection in or near the prostate, for example, with decreased catheter size farther away from the prostate to improve patient comfort.
[0035] The core 118 may be manufactured through extrusion in the preferred diameter or shape (e.g., Dc 124), cut to length, and machine finished. Alternatively, the core 118 may be cast into a specific shape to comply with anatomy and improve patient comfort. The sleeve 102 may be formed by pouring the sleeve material in liquid form, such as liquid silicone, into a room temperature vulcanization (RTV) mold shaped to the desired thickness, shape, distance, length, and so forth. The sleeve 102 may be cast onto an existing core insert (over-molded), or the core insert may be assembled into the catheter system 100 after the silicone or other material is cured, depending on desired design geometry. For example, the core can be inserted into the formed sleeve along the longitudinal axis.
[0036] Referring now to FIGS.4, 5A, 5B, and 5C, another example of a radioprotective catheter system 400 is illustrated. The catheter system 400 may further include a balloon port 402 that is located at or near the proximal end providing access to the balloon port 402 from outside of the patient. The balloon port 402 can be in fluid communication with a balloon 404 that is located distally from the balloon port 402. For example, the balloon 404 may be located at the farthest distal end of the catheter system 400 or may be located near or proximate to the distalend of the catheter system 400. Thus, the catheter system 400 extends along a longitudinal axis 406 from proximal end 408 to a distal end 410. The distal location of the balloon 404 may be determined by the distance through the urethra to the bladder of a patient, for example. In some configurations, the balloon may extend circumferentially about the sleeve of the catheter. The balloon 404 may be configured to fit into the bladder of the patient in order to hold the catheter system 400 in place while in use. Thus, the balloon 404 may be a foley catheter balloon.
[0037] Non-limiting examples of a cross-section of catheter system 400 are shown in FIGS. 5A, 5B, and 5C. As previously described, the catheter system 400 may include a flexible radioprotective core 504 within a closed lumen sleeve 502. The catheter system 400 may further include a balloon inflation lumen 506. The balloon inflation lumen 506 may be located within the sleeve 502 but outside the core 504. For example, the balloon inflation lumen may be located directly outside of the core 504, as shown in FIG.5A. Additionally or alternatively, the balloon inflation lumen 506 may include one or more channels embedded within the sleeve 502, such as those shown in FIG.5B. The balloon inflation lumen 506 may also be formed as a channel sandwiched between two sleeve layers 502a, 502b such that the channel extends along the whole circumferential direction 508 of the catheter system 400, as shown in FIG.5C.
[0038] The balloon inflation lumen 506 may be formed in the sleeve 502. For example, the space or channels for the balloon inflation lumen 506 may be included into the sleeve mold. After curing the sleeve 502, it can be dipped into a balloon material, such as latex, to create a thin balloon layer that can be in fluid communication with the balloon inflation lumen 506 and the balloon port 402. In another configuration, the catheter may be cast with a single main lumen open on both ends and a smaller lumen only open on one end. The side of the catheter can be punched, exposing the smaller lumen. Then, a thin film can be cast on top of the punched hole, creating the balloon. Regardless of the process for construction, in use, fluid, such as saline solution, may be pumped into the balloon port 402, through the balloon inflation lumen 506, and into the balloon 404 to inflate the balloon 404. For example, the balloon may be sized to facilitate 10 cc or another desirable measure of saline solution.
[0039] In some implementations, the radioprotective core can be formed from a single piece of continuous radioprotective material. Such material may be flexible (e.g., soft lead) to facilitate insertion into an anatomical lumen, as previously described. However, in other implementations, as illustrated in FIG.6, the radioprotective core can be formed from several pieces ofradioprotective material. FIG.6 illustrates another example catheter system 600, including a detailed view with the top layer removed to show a non-limiting example of the contents of the core. The core 604 can be defined by the inner wall of the sleeve 602 or may be defined by a separate lumen that runs through the sleeve 602.
[0040] In this example, the core 604 contains several radioprotective pellets 610. These pellets 610 can be spherical, ellipsoidal, another geometric shape, or an abnormal 3-dimensional shape. The pellets may be formed from a material that attenuates radiation, such as lead, tungsten, titanium, bismuth, gold, osmium, uranium, tantalum, impregnated polymer composite materials, or a combination thereof. In some configurations, the pellets 610 may be formed from a soft, pliable material. In other configurations, the pellets 610 may be hard and unpliable. In this case, flexibility of the core 604 can be provided by the space between pellets 610, allowing each pellet 610 to move with respect to its neighboring pellets 610 when the catheter system 600 is inserted into the patient. In this way, the core 604 is not required to be constructed from a flexible material, but the system still provides a flexible core that can increase patient comfort throughout catheter insertion, patient movement, and radiation therapy. The fill density of the core 604 can be determined based on the tradeoff between the effectiveness of radiation attenuation and the catheter flexibility that provides patient comfort. Various shaped and sized pellets 610 can be used to provide the desired flexibility. For example, the pellets 610 may include ellipsoids with the long axes aligned along the long axis 608 of the catheter. In this way, increased flexibility can be provided orthogonally to the axis 608 while flexibility is limited along the catheter’s longitudinal axis 608. The size of each pellet 610 can also be determined based on the tradeoff between core flexibility, radiation attenuation, and complexity of manufacturing or cost. In some implementations, each dimension (e.g., Dpx, Dpy, Dpz) of each pellet may be significantly smaller than the width of the core (e.g., Dc). For example, the size of the pellets 610 may be limited by Dpx, Dpy, and Dpz less than Dc / 4, Dc / 10, Dc / 50, Dc / 100, and so forth. While illustrated in the context of catheter system 600, the described features of a pellet- filled core can be used with other catheter systems (e.g., 100, 300, 400) described herein.
[0041] FIG.7 provides an illustrative example that may be used to estimate the dose reduction achieved by a radioprotective catheter system (e.g., 100, 300, 400, 600). As demonstrated in FIG.7, the radioprotective core may have a circular cross-sectional area with radius rc and that the radiation beams have perpendicular incidence when they contact the core.
[0042] a dose reduction can be calculated for a given path length ( ^^^) based on the definition of the mass attenuation coefficient: ୪୬ ^బఓ ൬^^ఘ ൌ^^ఘ௫^^3^ ^ఓ^^ ^^ ^ூబ
[1000] ^^describes core ^^^describes the path length through the core at each position ^^ along ^^ ( ^^^) and ^^^௫describes the intensity of the beam at a distance ^^^. For a circularly shaped core with radius ^^^, the path length ( ^^^) of the radiation through the core can be described for every position ( ^^) along y, called ^^^as: ^^^ൌ 2^ ^^^ଶെ ^^ଶ^ ^6^
[0043] Equation (6) can be adjusted for other core shapes or incidence angles of radiation based on the geometry of the core and radiation path through the core. Assuming a circular cross-sectional area, Equation (6) can be substituted into Equation (5) to describe the radiation dose reduction at ^^^. Thus, the percentage of reduction in the radiation dose at ^^^due to the attenuation properties of the core material with a mass attenuation coefficient of ^^ / ^^ can be described as: ூ^^ூబൌ ^ ഋ (7)
[0044] catheter cross-section. The radiation reduction increases with increasing distance (e.g., Dc) of the core, or radius ( ^^^^ for a circular core. Thus, the core may be designed to balance patient comfort with radiation dose reduction.
[0045] The radiation intensity ^ூబூ^^^ is plotted for several core materials in FIG.8 assuming the model as described in FIG.7 with a core radius of ^^^ൌ 3 mm. The following densities and mass coefficients were used: Material Density (ρ) [g / cm3] Mass coefficient (μ / ρ) at 6 MeV [cm2 / g] Lead 11.29 4.39 * 10-2Tungsten 19.3 4.21 * 10-2Bismuth 9.747 4.44 * 10-2Gold 19.3 4.36 * 10-2Osmium 22.5 4.24 * 10-2Uranium 18.95 4.58 * 10-2Tantalum 16.654 4.19 * 10-2
[0046] For example, using a lead core, the radiation toxicity to surrounding tissue can be reduced by more than 20% at the center of the core, which may allow for an increase in radiation dose by 20%, improving the efficacy of radiation therapy while protecting the surrounding healthy tissue.
[0047] It will be appreciated by those skilled in the art that while the invention has been described above in connection with particular embodiments and examples, the invention is not necessarily so limited, and that numerous other embodiments, examples, uses, modifications and departures from the embodiments, examples and uses are intended to be encompassed by the claims attached hereto. The entire disclosure of each patent and publication cited herein is incorporated by reference, as if each such patent or publication were individually incorporated by reference herein. Various features and advantages of the invention are set forth in the following claims.
Claims
CLAIMS 1. A catheter system for use with radiation therapy, the catheter system comprising: a core formed of a radioprotective material extending at least partially along a longitudinal axis extending from a proximal end to a distal end; and a sleeve formed from a biocompatible material extending about the core along the longitudinal axis and having an outer wall configured to extend through a biological lumen of a patient; and wherein the sleeve and core are configured to cooperate to reduce a radiation dose received by tissue or organs in the patient proximate to the catheter system by the core absorbing or scattering radiation incident upon the radioprotective material and the sleeve forming a barrier between the patient and the core.
2. The catheter system of claim 1, wherein the sleeve forms a closed lumen fully surrounding the core in a circumferential direction transverse to the longitudinal axis.
3. The catheter system of claim 1, wherein the radioprotective material comprises soft lead.
4. The catheter system of claim 1, wherein the radioprotective material comprises at least one of lead, tungsten, titanium, bismuth, gold, osmium, uranium, tantalum, or an impregnated polymer composite material.
5. The catheter system of claim 1, wherein the catheter system is dimensioned to fit into a urethra of the patient.
6. The catheter system of claim 1, wherein the sleeve comprises at least one of silicone, latex rubber, polytetrafluoroethylene, or other polymer material.
7. The catheter system of claim 1, wherein the sleeve is configured to absorb radiation incident thereupon.
8. The catheter system of claim 1, wherein the sleeve has a thickness of at least 0.1 mm.
9. The catheter system of claim 1, wherein the core has a distance of at least 2.0 mm.
10. The catheter system of claim 1, further comprising a balloon inflation lumen.
11. The catheter system of claim 10, wherein the balloon inflation lumen is positioned between the core and the sleeve.
12. The catheter system of claim 10, wherein the balloon inflation lumen is formed as a channel in the sleeve.
13. The catheter system of claim 10, wherein the balloon inflation lumen is formed from latex.
14. The catheter system of claim 10, further comprising a foley catheter balloon extending about the sleeve proximate to the distal end and in fluid communication with the balloon inflation lumen.
15. The catheter system of claim 14, wherein the catheter balloon is configured to be received by a bladder of the patient.
16. The catheter system of claim 10, further comprising a balloon port coupled to the sleeve and in fluid communication with the balloon inflation lumen.
17. The catheter system of claim 1, wherein the core is flexible.
18. The catheter system of claim 1, wherein the core comprises a plurality of pellets, wherein each of the plurality of pellets is formed of a radioprotective material.
19. A catheter system for use with radiation therapy, the catheter system comprising:a core formed of a radioprotective material extending from a proximal end to a distal end along a longitudinal axis, the core being configured to absorb or scatter radiation incident upon the radioprotective material to reduce a radiation dose received by tissue or organs in the patient proximate to the catheter system; and a sleeve formed from a biocompatible material, the sleeve extending about the core along the longitudinal axis and having an outer wall; wherein the catheter system is configured to extend through a biological lumen of a patient.
20. A method of manufacturing a radioprotective catheter system, the method comprising: forming or shaping a core extending from a proximal end to a distal end along a longitudinal axis, the core comprising a radioprotective material; and forming a sleeve from a biocompatible material about the core along the longitudinal axis, the sleeve forming a closed lumen surrounding the core; and wherein the catheter system is configured to extend through a biological lumen of a patient.
21. The method of manufacturing of claim 20, wherein forming the sleeve about the core comprises casting the sleeve onto the core.
22. The method of manufacturing of claim 20, wherein forming the sleeve about the core comprises inserting the core into the sleeve along the longitudinal axis.
Citation Information
Patent Citations
Catheter with inflatable balloon assembly and optically activated x-ray source
US20060126789A1
Catheter apparatus and brachytherapy system
US20200139155A1
Intravascular radiation therapy device and method of use
US6338709B1
Surface modified reinforcing member for medical device and method for making same
US7744587B2
Brachytherapy device
US8517906B2
